Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc. | Practical Law
Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc.
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc.
Ipsen S.A. acquisition of certain assets of Merrimack Pharmaceuticals, Inc.
January 07, 2017
•
Private Acquisition Agreements
•
$575 million (subject to purchase price adjustment and additional earn-out payment).
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.
Back to top